Investigation Overview
November 16, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Ocata Therapeutics Inc (NASDAQ:OCAT), was announced concerning whether the takeover of Ocata Therapeutics Inc by Astellas Pharma Inc is unfair to NASDAQ:OCAT stockholders. The investigation by a law firm concerns whether certain officers and directors of Ocata Therapeut...
You must register (for free) or login to view the entire investigation.